ASArmen K. Shakaryan

Armen K. Shakaryan

*This is an algorithmically generated author record based on publicly available information.

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Armen K. Shakaryan has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Severe foodborne botulism: patterns of neurophysiological changes during the acute phase of the disease

    by D. A. Grishina, N. A. Suponeva, A. K. Shakaryan, A. M. Narbut, E. A. Lyapeykova, Д. А. Гришина, Н. А. Супонева, А. К. Шакарян, А. М. Нарбут, Е. А. Ляпейкова

    Foodborne botulism is a rare, acute neuromuscular disorder of infectious-toxic origin, caused by the neurotoxin produced by Clostridium botulinum. In severe cases of foodborne botulism, characterized by the acute onset of flaccid tetraparesis, severe oculomotor and bulbar disorders, there are reasonable difficulties in differential diagnosis with phenotypically similar diseases– Guillain–Barre syndrome and autoimmune myasthenia gravis. In this regard, a detailed description of the neurophysiological changes associated with botulism is essential, as this will facilitate the differential diagnostic process and enable a correct diagnosis to be established in a timely manner. Objective: to demonstrate the pattern of neurophysiological changes in patients with severe foodborne botulism during the acute phase. Material and methods. The study included 27 patients. The inclusion criteria were a confirmed diagnosis of ‘foodborne botulism’, the acute phase (disease duration of less than 14 days) and a severe form of the disease (requiring mechanical ventilation). The study methods included an analysis of discharge summaries and a neurophysiological examination to assess the conduction function of the long limb nerves, with an examination of the deltoid muscle using a needle electrode, a decrement test, and analysis of the jitter of the orbicularis oculi muscle. Results. In patients with severe foodborne botulism during the acute phase, no disturbances in conduction function and/or damage to the axons of motor and sensory fibers of the peripheral nerves of the limbs were detected. Low-amplitude motor responses were recorded from the paretic muscles (facial and bulbar groups); the degree of paresis of the orbicularis oculi muscle correlated with the M-response amplitude from this muscle (pConclusion. The analysis of jitter of the facial muscles proved to be the most informative method for verifying neuromuscular transmission disorders in patients with severe foodborne botulism. The low amplitude of the motor response and the absence of pathological changes in half of the patients during decrement and increment tests of the paretic muscles are due to the severity of the neuromuscular transmission disorder – a severe presynaptic block. It should be borne in mind that all recorded neurophysiological changes in severe foodborne botulism are non-specific and must be considered strictly in combination with clinical and anamnestic data. The data obtained from this study will help to improve the differential diagnosis of acute flaccid tetraparesis syndrome and enable the timely confirmation of foodborne botulism.

  • Echovirus 19 Molecular Epidemiology in Russia and Some Central Asian Countries in 1999–2024

    by Elizaveta V. Yakovchuk, Elena Yu. Shustova, Liudmila N. Galitzina, Evgenia V. Karpova, Olga Yu. Baykova, Mahtob Bobokhonova, Saidzoda Faizali Barot, Sachly A. Nuryeva, Maral Aksakowa, Aichurok Makilova, et al.

    Echovirus 19 (E19) is a rarely reported non‐polio enterovirus (NPEV), although it has been associated with a spectrum of severe syndromes, including encephalitis, meningitis, and multisystem hemorrhagic disease in infants. Moreover, Echovirus 19 has been detected in patients with acute flaccid paralysis (AFP), suggesting a potential association between viral infection and CNS damage. Here we describe molecular epidemiology of Echovirus 19 in Russia and Central Asia from 1999 to 2024 using data on poliomyelitis surveillance. Echovirus 19 accounted for no more than 4% of annual NPEV isolates, however, in 2022 abundance rate dramatically increased making this virus the most frequently isolated NPEV from AFP cases (14.3% of NPEV‐positive AFP cases). Phylogenetic analysis revealed that contemporary (2020–2025) regional isolates formed a distinct, well‐supported clade sharing a common ancestor with Echovirus 19 variants isolated from AFP cases in Iran and Pakistan in 2013. Notably, these recent isolates lack sustained country‐specific sublineages indicating ongoing cross‐border circulation. A novel A83S mutation in the BC‐loop of the VP1 antigenic region was identified in 75% isolates collected in 2022–2025. The emergence of this variant highlights the need for continued surveillance and further investigation into the Echovirus 19 possible role in neurological diseases.

  • Open Access

    Epidemiological surveillance for poliomyelitis and acute flaccid paralysis in the Russian Federation in 2013–2024

    by Yulia М. Mikhailova, Alina V. Chirova, Evgeniya А. Cherepanova, Nadezhda S. Morozova, Armen К. Shakaryan, Liubov I. Kozlovskaya, Olga E. Ivanova

    Introduction. The goal of the WHO Global Polio Eradication Initiative has not yet been solved, and the surveillance of diseases with acute flaccid paralysis (AFP) remains its key element. It is still relevant for ensuring the sanitary and epidemiological well-being of Russia. Aim: analysis of indicators and results of polio/AFP surveillance in 2013-2024 for purposes of surveillance quality assessment and improvement. Materials and methods. Information on surveillance indicators and results of virological investigation was obtained in national reporting documents. Results. Over 12 years, 5,016 cases of AFP have been registered. Surveillance quality indicators were generally in line with WHO recommendations, but the COVID-19 pandemic had a negative impact on the detection of AFP cases at the clinical level. The majority of patients were children under 5 years of age (50.54%), boys (58.8%), the majority (82.46%) were vaccinated against polio. Polioviruses (PV) were isolated from 1.85% of cases, PV3 (48.4%) prevailed, non-polio enteroviruses — from 1.46% cases, CVB1–6 (34.9%) and EV-A71 (17.5%) were predominant. The majority of AFP cases (30.78%) were polyradiculoneuropathies, 34 cases (0.68%) were poliomyelitis. The occurrence of 30 cases of vaccine-associated paralytic poliomyelitis was associated with violations of sanitary and epidemiological requirements for its prevention. Four cases were associated with PV of vaccine origin (VDPV) types 1 and 3. The "age" of VDPVs corresponded to 1-2 years of circulation, there was no genetic evidence of human-to-human transmission. Conclusion. High level of polio/AFP surveillance in Russia allowed to identify epidemiologically significant PVs and timely carry out anti-epidemic measures. The continuing threat of the international spread of poliomyelitis is the basis for future improving surveillance. The surveillance platform provides information about other (non-polio) pathogens that cause diseases with AFP syndrome.

  • The significance of Cerebrospinal fluid/Serum ratios of interleukins-6, -8, -10 in the differential diagnosis of meningitis in children

    by A. M. Deomkina, R. F. Sayfullin, A. K. Shakaryan, G. D. Guseva, T. V. Gorkov, O. V. Shamsheva

    Meningitis is a devastating disease for which appropriate initial treatment improves outcome. Management strategies are based on the etiology, which is most commonly bacterial or viral. However, prompt detection of the etiologic agent is not possible in all cases; therefore, the investigation of additional early differential diagnostic markers, such as interleukins, remains relevant. The aim of the study. To determine the differential diagnostic value of cerebrospinal fluid/serum ratios of interleukins 6, 8, 10 in purulent bacterial and viral meningitis in children. Materials and Methods. This prospective study enrolled 63 children, divided into three groups: bacterial meningitis (n=20), viral meningitis (n=17), and a control group (n=26). Concentrations of albumin, interleukins 6, 8, 10 were evaluated in cerebrospinal fluid and serum samples obtained in parallel on the day of admission. Cerebrospinal fluid/serum ratios (QAlb and QIL) were calculated. Receiver operating characteristic (ROC) curve analysis was performed with estimation of the area under the curve (AUC) and determination of optimal cut-off values. A predictive model was developed with binary logistic regression. Results. Interleukin 6 concentrations in cerebrospinal fluid (AUC = 0.982) and serum (AUC = 0.991), serum interleukin 10 (AUC = 0.965), and QIL10 (AUC = 0.953; sensitivity = 95.0%, specificity = 76.5%) demonstrated high diagnostic accuracy in differentiating bacterial from viral meningitis. Combining QAlb and QIL10 in the predictive model equation increased sensitivity (100%) and specificity (88.2%). A possible mechanism of intrathecal regulation of inflammation in the early stages of meningitis is proposed. In bacterial meningitis, only pro-inflammatory interleukins 6 and 8 are synthesized intrathecally, resulting in neutrophilic pleocytosis. In viral meningitis, intrathecal production of interleukins 6 and 8 and anti-inflammatory interleukin 10 inhibiting neutrophil recruitment into the cerebrospinal fluid leads to mixed or lymphocytic pleocytosis. Conclusion. Evaluation of interleukin 6 concentration in cerebrospinal fluid and application of the predictive formula incorporating QAlb and QIL10 enables differentiation between bacterial and viral meningitis at the early stages of the disease.

  • Clinical, anamnestic and laboratory features in children with early stages of meningitis

    by A. M. Demkina, A. K. Shakaryan, G. D. Guseva, O. V. Shamsheva, R. F. Saifullin

    This article presents the results of a study aimed at identifying the clinical, anamnestic, and laboratory features of bacterial and viral meningitis in children on the first disease days. Materials and Methods : This prospective study included 37 children with etiologically confirmed meningitis (bacterial purulent (n = 20) and viral (n = 17) and 26 children with meningism. Following standardized protocols, the medical histories data, results of physical examination, and laboratory tests (blood and CSF) were obtained. ROC curve analysis was performed, and a predictive model was constructed using binary logistic regression. Results: The duration of general cerebral symptoms as the first signs of meningitis syndrome was: in group №1 — 1.0 [1.0—2.0], №2 — 1.0 [1.0—3.0], №3 — 2.0 [1.0—4.0] days (p = 0.309). Altered level of consciousness increased the odds (odds ratio) of bacterial etiology by 17.5 times (95% CI 3.016—101.54). The following symptoms were sensitive for the meningitis in the first days: neck stiffness (Se = 89.2%; Sp = 38.5%), the «seating» symptom (Se = 77.8%; Sp = 44.0%). There were no significant differences in meningeal symptoms in the early stages of the disease between viral and bacterial meningitis. Laboratory tests of bacterial meningitis in our study were characterized by high C-reactive protein levels and neutrophilic leukocytosis with lymphopenia. In the first days of general cerebral symptoms of bacterial meningitis, elevated CSF lactate concentrations (> 3.45 mmol/L) (Se = 80%, Sp = 100%) are typical. Conclusions : The clinical presentation of acute meningitis in the early stages exhibits typical symptoms of varying severity. However, physical examination alone does not allow for a clear differentiation of the etiology, necessitating the search for sensitive and specific laboratory markers for differential diagnosis.

  • Open Access

    Botulism Sequelae: A Systematic Review

    by Mark Kosenko, Veronika Rogozhina, Tamerlan Erdniev, Armen K Shakaryan, Dmitry Tumurov, Ekaterina Ligskaya, Svetlana Gadetskaya, Alina Eremeeva, Margarita Andreeva, Maria Pyatnitskaya, et al.

    Background: Botulism is a life-threatening neuroparalytic disease caused by botulinum neurotoxins. While its acute phase has been extensively studied, long-term sequelae following recovery remain insufficiently explored. This systematic review aims to comprehensively assess and synthesize available evidence on post-botulism sequelae to improve understanding and guide future research. Methods: A systematic search was conducted in MEDLINE, EMBASE via Ovid, and Web of Science from inception to 24 June 2024. Eligible studies included observational studies, case series, and case reports describing post-recovery symptoms in individuals diagnosed with foodborne, wound, or infant botulism, excluding iatrogenic cases. The risk of bias was assessed using the Critical Appraisal Skills Programme (CASP) checklists. Results: Out of 340 screened records, 9 studies met inclusion criteria, comprising 2 case-control studies (n = 230 botulism cases, n = 669 controls) and 7 cohort studies (n = 185 botulism cases). Most studies reported some short- and/or long-term consequences of botulism. Among 3 studies homogeneously reporting sequelae symptomatology, the most frequently reported long-term symptoms included fatigue (66.2%, range 47.9%–84.6%), limitations in vigorous activities (55.8%, range 47.6%–64.0%), general weakness (57.1%, range 43.1%–76.9%), and dyspnea (42.9%, range 18.0%–92.3%). In some patients, psychosocial dysfunction persisted longer than physical impairments, over the 6-year period post intoxication. Two studies provided comparative data with control groups, demonstrating significantly higher prevalence of fatigue, weakness, and impaired health perception in botulism survivors. Additionally, 14 case reports and case series (n = 43 individuals) reported similar patterns with dyspnea, fatigue, and autonomic dysfunction among the most reported sequelae. Conclusions: This systematic review highlights significant long-term sequelae among botulism survivors, particularly fatigue, respiratory impairment, and psychosocial dysfunction. While recovery trajectories suggest improvement over time, persistent symptoms may impact quality of life. Standardized outcome measures and longitudinal studies are needed to elucidate the burden of post-botulism sequelae further and inform clinical management strategies.


  • Acute Flaccid Paralysis in a Vaccinated Child With Primary Immunodeficiency: Difficulties With Diagnostics of Vaccine‐Associated Paralytic Poliomyelitis

    by Armen K. Shakaryan, Yulia M. Mikhailova, Alina V. Chirova, Evgeniya A. Cherepanova, Olga Y. Baikova, Elizaveta V. Yakovchuk, Evgenia V. Karpova, Aleksander P. Ivanov, Svetlana V. Skryabina, Tatiana E. Snitkovskaya, et al.

    Oral polio vaccine (OPV) from attenuated Sabin strains widely used for poliomyelitis prevention and eradication along with undeniable advantages has significant disadvantages, one of which is the ability to cause cases of vaccine‐associated paralytic poliomyelitis (VAPP). Inactivated poliovirus vaccine (IPV) introduction into the national immunization schedules of countries that continue to use OPV allows effective prevention of VAPP cases and simultaneously forms immunity to PV type 2. The present study presents an example of VAPP development in a child with Bruton's disease, born by in vitro fertilization, vaccinated with four IPV doses followed by one bOPV dose, and paralysis onset 52 days bOPV vaccination. Despite objective clinical, laboratory and instrumental signs of anterior corneal myelitis, the isolation of Sabin‐like poliovirus, and contradictory results of serological investigation, diagnostics caused significant difficulties for the treating physicians. The case was associated with a recombinant poliovirus of vaccine Sabin strains types 3 and 1 with a recombination point in 2C‐encoding genome region, containing known neurovirulence reverse mutations and some unique ones. The introduction of IPV doses for primary immunization increases the safety of immunization against polio; however, while OPV is in use there is still a VAPP threat for immunocompromised children and unvaccinated contacts.


  • Open Access

    Guillain–Barré syndrome in children: clinical and diagnostic features

    by Анастасия Андреевна Козырева, Раиса Цеденкаевна Бембеева, Евгения Сергеевна Дружинина, Armen K. Shakaryan, Галина Дмитриевна Гусева, Сергей Генрихович Беседин, Николай Николаевич Заваденко

    Introduction. In 2025, we will commemorate the 100th anniversary of the first pediatric case of Guillain–Barré Syndrome (GBS), initially documented by M. Monnier-Vinard. This significant milestone invites a reevaluation of our contemporary understanding of GBS in children. While the original description of GBS was thorough, the categorization has expanded over time to include a wider array of conditions, resulting in the term applied to various acute demyelinating polyneuropathies. The atypical forms of GBS present notable diagnostic challenges for healthcare providers. Objective. To analyze the demographic and clinical characteristics, treatment methods, and prognosis of GBS in children in Russia. Materials and methods. The study included fifty 6 months – 15 years patients with typical and atypical forms of Guillain-Barré syndrome (GBS). Neurological status was assessed using the Medical Research Council sum score and the Hughes disability scale. Additionally, data from cerebrospinal fluid analysis, nerve conduction study, magnetic resonance imaging of the spine, and peripheral nerves ultrasound was evaluated. Results. The classic ascending subtype of GBS was diagnosed in 30 (60%) patients, while atypical manifestations were observed in 17 (34%). Three (6%) patients had an overlap syndrome: GBS with acute myelitis. The median age of the patients was 7 [5.0; 11.0] years. Two peaks of GBS incidence associated with respiratory and gastrointestinal infections were identified. The most common initial symptoms were pain (80%), weakness in the legs (64%), and difficulty walking (54%). All 26 (100%) GBS patients were followed for 12 months from the onset of the disease regained the ability to walk. Conclusion. Both typical and atypical forms of GBS can occur in children. Overlap syndrome (GBS with acute myelitis) is a rare complication following COVID-19 and may go undiagnosed. With appropriate therapy the prognosis for both typical and atypical forms of GBS is generally favourable.


  • Open Access

    The diagnostic value of cerebrospinal fluid and serum indices in neuroborreliosis

    by R.F. Sayfullin, A.K. Shakaryan, Moscow Infectious Clinical Hospital No. 1, K.A. Kiseleva

    Диагностическое значение ликворо-сывороточных индексов при нейроборрелиозе

  • Subacute sclerosing panencephalitis in children: series of clinical case reports

    by R.TS. Bembeyeva, E.L. Usacheva, S.V. Piliya, E.S. Ilyina, A.K. Shakaryan, A.S. Kozlovskiy, L.M. Kolpakchi, A.A. Kozyreva, I.D. Fedonyuk

    Subacute sclerosing panencephalitis (SSPE) is a rare complication caused by persistent measles infection and characterized by a decline in cognitive functions and severe motor impairments. Since SSPE is considered a potentially fatal complication of acute measles infection and is typically develops in young individuals especially those infected prior to the age of two years old, special attention must be paid to the implementation of vaccination programs that can prevent severe disease. Thus, the purpose of this research was to present the demographic and clinical characteristics of pediatric patients with SSPE in order to enhance its early diagnosis and to raise the pediatricians' awareness of this serious measles complication. In this series of case reports Authors represent the clinical picture, laboratory and instrumental data of six children with SSPE admitted at the Russian Children's Clinical Hospital with the Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Moscow, Russia) in Aug. 2022-Aug. 2024. Authors have conducted an analysis of complaints, clinical symptoms, laboratory, neurophysiological and neuroimaging data of 6 patients with SSPE. All patients have undergone cerebrospinal fluid (CSF) analysis, magnetic resonance imaging (MRI) of the brain and video EEG monitoring during both wakefulness and sleep at the time of diagnosis. Currently, there is no specific treatment for SSPE that would either lead to symptom regression or prevent the related disability. Therefore, vaccination remains the only effective means for the SSPE prevention.